Reduced cognitive decline in Bri2-Abeta40/42 expressing transgenic mice compared to controls suggests that this specific mechanism normally serves to prevent or delay processes that much later result in the development of AD (Kim J. et al., 2013). The gene discussed is APP; the disease is Alzheimer disease.